Atrial Fibrillation Market

Future Market Insights

Key Insight

The atrial fibrillation market is projected to grow from USD 29.7 billion in 2025 to USD 80.1 billion by 2035, at a CAGR of 10.4%. Pharmacological Treatment will dominate with a 66.5% market share, while hospitals will lead the end-use outlook segment with a 60.4% share.

September 22, 2025

Anurag Sharma

250 Pages

Cite this Report

Atrial Fibrillation Market

https://www.futuremarketinsights.com/reports/atrial-fibrillation-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott (St. Jude Medical Inc.)
AtriCure Inc
Biosense Webster Inc
Boehringer Ingelheim
Boston Scientific
Bristol-Myers Squibb
Cardio Focus Inc
CardioFocus Inc
Endoscopic Technologies Inc
The Vanguard Group
Sanofi-Aventis

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Atrial Fibrillation Market

Key Players

Similar Industry Reports